Skip to main content
OpenTrials

Clinical trial condition

Recurrent Salivary Gland Cancer

Explore clinical trials studying Recurrent Salivary Gland Cancer. Study availability and eligibility vary by location and protocol.

32 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Salivary Gland Cancer trial results

Completed

Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab

NCT00939627

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +49 more
Locations
  • H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • Suburban Hospital Bethesda, Maryland, United States
View Trial Details
Completed

Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy

NCT02123511

Conditions
Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +98 more
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • State University of New York Upstate Medical University Syracuse, New York, United States
  • Bismarck Cancer Center Bismarck, North Dakota, United States
View Trial Details

Related conditions